Company: XERI
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001477932-25-001010
Chunk: 6

Company: XERIANT, INC.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
 stock  -   -   -   -   25,511,500   255   -   254,860   -   -   255,115                                              Net loss  -   -   -   -   -   -   -   -   (1,199,183 )  (7,712 )  (1,206,895 )                                             Balance December 31, 2023  733,895  $7   1,000,000  $10   445,044,644  $4,450  $51,950  $20,110,352  $(25,171,734 ) $(2,842,928 ) $(7,847,893 )

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 F-5Table of Contents

XERIANT, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSUNAUDITED         For the six months ended   December 31,   2024  2023        Cash Flows from Operating Activities      Net Loss $(789,491) $(1,548,907)Adjustments to reconcile net loss to net cash used by operating activities:        Depreciation and amortization  756   756 Stock option expense  -   - Stock issued for services  284,006   - (Gain) loss on extinguishment of debt  (60,157)  20,298 Change in fair value of convertible bridge loans  -   2,448 Amortization of debt discount  42,274   - Amortization of right of use asset  27,515   24,628 Changes in operating assets and liabilities:        Prepaids and deposits  1,050   (1,755)Accounts payable and accrued liabilities  (214,320)  897,545 Accrued liability, related party  (7,500)  (12,500)Shares to be issued  (4,250)  - Lease liabilities  (30,805)  (26,994)Net cash from operating